Anıl Tombak

About Anıl Tombak

Anıl Tombak, With an exceptional h-index of 15 and a recent h-index of 12 (since 2020), a distinguished researcher at Mersin Üniversitesi, specializes in the field of hematoloji, iç hastalıkları.

His recent articles reflect a diverse array of research interests and contributions to the field:

Erdheim-Chester disease in a psoriatic arthritis patient

Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

MDS-143 Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

P1073: A NEW SCORING SYSTEM TO PREDICT SURVIVAL IN ELDERLY ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS: STUDY BY TURKISH SOCIETY OF HAEMATOLOGY LYMPHOMA ACADEMY WORKING GROUP

A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real-Life Multicenter Experience on Off-Label Use of Ibrutinib

Primary Thyroid Lymphoma: A Nationwide Retrospective Cohort Analysis of Survival and Determinant Factors

Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden …

Anıl Tombak Information

University

Position

Tıp Fakültesi

Citations(all)

677

Citations(since 2020)

406

Cited By

421

hIndex(all)

15

hIndex(since 2020)

12

i10Index(all)

19

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Anıl Tombak Skills & Research Interests

hematoloji

iç hastalıkları

Top articles of Anıl Tombak

Erdheim-Chester disease in a psoriatic arthritis patient

Archives of Rheumatology

2024

Anıl Tombak
Anıl Tombak

H-Index: 9

Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

Hematological oncology

2023/10

MDS-143 Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Anıl Tombak
Anıl Tombak

H-Index: 9

P1073: A NEW SCORING SYSTEM TO PREDICT SURVIVAL IN ELDERLY ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS: STUDY BY TURKISH SOCIETY OF HAEMATOLOGY LYMPHOMA ACADEMY WORKING GROUP

HemaSphere

2023/8/1

A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

İstanbul Medical Journal

2023

Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real-Life Multicenter Experience on Off-Label Use of Ibrutinib

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI

2023

Primary Thyroid Lymphoma: A Nationwide Retrospective Cohort Analysis of Survival and Determinant Factors

2023/11/30

Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden …

Blood

2023/11/28

Expression levels and clinical significances of hsa-miR-29 family and their target genes in the bone marrow of patients with multiple myeloma

Indian Journal of Experimental Biology (IJEB)

2023/11/24

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo …

The Lancet

2023/11/4

Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study

European journal of internal medicine

2022/6/1

Multiple Nervous System Involvement of Erdheim-Chester Disease With Responsive Perinephritic Hypermetabolism

Clinical Nuclear Medicine

2022/5/11

Anıl Tombak
Anıl Tombak

H-Index: 9

Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?

Medical Science and Discovery

2022/2/18

Integration of low muscle mass into the IPS system and its prognostic significance in patients with Hodgkin's lymphoma

Biomarkers in Medicine

2022/2

Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study

Cureus

2022/1/4

Outcome in patients with peripheral T-cell lymphoma treated with pralatrexate, single center experience

Turkish Journal of Internal Medicine

2022/1/1

Nurcan Yilmaz
Nurcan Yilmaz

H-Index: 2

Anıl Tombak
Anıl Tombak

H-Index: 9

CCAAT Enhancer-binding Protein Alpha (CEBPA) Gene Expression in a Cohort of Turkish Patients with Multiple Myeloma.

Turkish Journal of Oncology/Türk Onkoloji Dergisi

2022/1/1

An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients

Archives of Medical Science: AMS

2021

Efficacy and safety of ibrutinib therapy in patients with chronic lymphocytic leukemia: retrospective analysis of real-life data

Turkish Journal of Hematology

2021/12

Vaccination rates among adults with sickle cell disease: a single-center study from the Eastern Mediterranean region of Turkey: Vaccination status of adult patients with sickle …

Medical Science and Discovery

2021/11/23

See List of Professors in Anıl Tombak University(Mersin Üniversitesi)